ask="N/A"
ask_size="N/A"
average_daily_volume="1697"
bid="N/A"
bid_size="N/A"
book_value="0.00"
change="-0.01"
change_from_200_day_moving_average="-0.11"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-1.12"
change_From_52_week_low="0.53"
change_in_percent="-1.27%"
close="0.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.78"
high_52_weeks="1.90"
last_trade_date="1/5/2017"
last_trade_price="0.78"
last_trade_size="100"
last_trade_time="3:12pm"
low="0.78"
low_52_weeks="0.25"
market_capitalization="N/A"
moving_average_200_day="0.89"
moving_average_50_day="0.69"
name="Oncobiologics
Inc. - Series B "
notes="N/A"
one_year_target_price="N/A"
open="0.78"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-12.10%"
percent_change_from_50_day_moving_average="+13.51%"
percent_change_from_52_week_high="-58.95%"
percent_change_from_52_week_low="+212.00%"
previous_close="0.79"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NGM"
symbol="ONSIZ"
volume="150"
weeks_range_52="0.25 - 1.90"
